AK Medical Holdings Reports 5.6% Rise in Revenue and 15.3% Increase in Profit for H1 2025

Reuters

Sep 30

AK Medical Holdings Reports 5.6% Rise in Revenue and 15.3% Increase in Profit for H1 2025

For the six months ended 30 June 2025, the Group reported revenue of RMB694.2 million, an increase of 5.6% compared to RMB657.1 million for the same period in 2024. Gross profit was RMB410.3 million, up 3.0% from RMB398.5 million. Profit for the period was RMB160.6 million, a 15.3% increase from RMB139.3 million in the previous year. Gross margin for the period was 59.1%, compared to 60.6% for the same period in 2024. Cost of sales amounted to RMB283.9 million, up 9.8% from RMB258.6 million. Other income was RMB18.3 million, compared to RMB2.9 million for the same period in 2024. Selling and distribution expenses totaled RMB117.3 million, a 3.8% increase from RMB113.0 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AK Medical Holdings Ltd. published the original content used to generate this news brief on September 30, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2571933312"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2571933312\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2571933312?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-30 16:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2571933312","market":"fut","top_or_hot":-1,"title":"AK Medical Holdings Reports 5.6% Rise in Revenue and 15.3% Increase in Profit for H1 2025","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      AK Medical Holdings Reports 5.6% Rise in Revenue and 15.3% Increase in Profit for H1 2025\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        For the six months ended 30 June 2025, the Group reported revenue of RMB694.2 million, an increase of 5.6% compared to RMB657.1 million for the same period in 2024. Gross profit was RMB410.3 million, up 3.0% from RMB398.5 million. Profit for the period was RMB160.6 million, a 15.3% increase from RMB139.3 million in the previous year. Gross margin for the period was 59.1%, compared to 60.6% for the same period in 2024. Cost of sales amounted to RMB283.9 million, up 9.8% from RMB258.6 million. Other income was RMB18.3 million, compared to RMB2.9 million for the same period in 2024. Selling and distribution expenses totaled RMB117.3 million, a 3.8% increase from RMB113.0 million.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AK Medical Holdings Ltd. published the original content used to generate this news brief on September 30, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AK Medical Holdings Reports 5.6% Rise in Revenue and 15.3% Increase in Profit for H1 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAK Medical Holdings Reports 5.6% Rise in Revenue and 15.3% Increase in Profit for H1 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-09-30 16:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      AK Medical Holdings Reports 5.6% Rise in Revenue and 15.3% Increase in Profit for H1 2025\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        For the six months ended 30 June 2025, the Group reported revenue of RMB694.2 million, an increase of 5.6% compared to RMB657.1 million for the same period in 2024. Gross profit was RMB410.3 million, up 3.0% from RMB398.5 million. Profit for the period was RMB160.6 million, a 15.3% increase from RMB139.3 million in the previous year. Gross margin for the period was 59.1%, compared to 60.6% for the same period in 2024. Cost of sales amounted to RMB283.9 million, up 9.8% from RMB258.6 million. Other income was RMB18.3 million, compared to RMB2.9 million for the same period in 2024. Selling and distribution expenses totaled RMB117.3 million, a 3.8% increase from RMB113.0 million.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AK Medical Holdings Ltd. published the original content used to generate this news brief on September 30, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01789","symbol_name":"爱康医疗","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nNDL1sDDvb:1","article_id":"2571933312","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2571933312","pubTimestamp":1759221532,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"For the six months ended 30 June 2025, the Group reported revenue of RMB694.2 million, an increase of 5.6% compared to RMB657.1 million for the same period in 2024. Gross profit was RMB410.3 million, up 3.0% from RMB398.5 million. Profit for the period was RMB160.6 million, a 15.3% increase from RMB139.3 million in the previous year. Gross margin for the period was 59.1%, compared to 60.6% for the same period in 2024. Cost of sales amounted to RMB283.9 million, up 9.8% from RMB258.6 million. Other income was RMB18.3 million, compared to RMB2.9 million for the same period in 2024. Selling and distribution expenses totaled RMB117.3 million, a 3.8% increase from RMB113.0 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AK Medical H","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01789":"爱康医疗","BK1583":"高瓴概念","BK1617":"AI医疗","BK1100":"医疗保健设备","BK1585":"昨日强势股"},"translate_title":"爱康医疗控股报告2025年上半年收入增长5.6%，利润增长15.3%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01789":0.9},"content_text":"AK Medical Holdings Reports 5.6% Rise in Revenue and 15.3% Increase in Profit for H1 2025\n    \n\n        For the six months ended 30 June 2025, the Group reported revenue of RMB694.2 million, an increase of 5.6% compared to RMB657.1 million for the same period in 2024. Gross profit was RMB410.3 million, up 3.0% from RMB398.5 million. Profit for the period was RMB160.6 million, a 15.3% increase from RMB139.3 million in the previous year. Gross margin for the period was 59.1%, compared to 60.6% for the same period in 2024. Cost of sales amounted to RMB283.9 million, up 9.8% from RMB258.6 million. Other income was RMB18.3 million, compared to RMB2.9 million for the same period in 2024. Selling and distribution expenses totaled RMB117.3 million, a 3.8% increase from RMB113.0 million.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AK Medical Holdings Ltd. published the original content used to generate this news brief on September 30, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"executive,dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}